Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

2017 Clinical_efficacy_of_intravitreal_aflibercept_paper
Llawysgrif awdur wedi’i dderbyn, 407 KB, dogfen-PDF
Trwydded: CC BY-NC-ND Dangos trwydded

S. Sivaprasad
National Institute for Health Research
A.T. Prevost
Grand Challenges in Ecosystem and the Environment Initiative, Imperial College London, Silwood Park Campus, Ascot, Berkshire SL5 7PY, UK alexander.papadopulos@plants.ox.ac.uk.
J. C Vasconcelos
Grand Challenges in Ecosystem and the Environment Initiative, Imperial College London, Silwood Park Campus, Ascot, Berkshire SL5 7PY, UK alexander.papadopulos@plants.ox.ac.uk.
Riddell A
King's College London
C Murphy
King's College London
J Kelly
King's College London
Bainbridge J
University College London
Rhiannon Tudor Edwards
[Pre-Aug 2018] Ysgol Nyrsio, Bydwreigiaeth ac Astudiaethau Iechyd
David Hopkins
King's College London
Philip Hykin
National Institute for Health Research

Iaith wreiddiol	Saesneg
Tudalennau (o-i)	2193-2203
Cyfnodolyn	The Lancet
Cyfrol	389
Rhif y cyfnodolyn	10085
Dyddiad ar-lein cynnar	7 Mai 2017
Dynodwyr Gwrthrych Digidol (DOIs)	https://doi.org/10.1016/S0140-6736(17)31193-5
Statws	Cyhoeddwyd - 3 Meh 2017

Cyfanswm lawlrlwytho

Nid oes data ar gael